This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
What pharmacists should know about the blockbuster drugs of 2023 Blockbuster drugs are medications that generate significant annual revenue ($1 billion or more) for pharmaceuticalcompanies. But it’s not always easy to tell when a prescription is invalid or if a controlledsubstance is being misused. Read more here.
Commercially Unavailable Medications Some medications are not profitable enough for large pharmaceuticalcompanies to make. A compounding pharmacy is regulated by three government agencies, namely state boards of pharmacy, the FDA, and the Drug Enforcement Administration (for compounding pharmacies that handle controlledsubstances).
generic drugs at both small development companies and multinational pharmaceuticalcompanies. This unique pedigree gives the company a foundational understanding of how to launch products at every stage of development. This will help determine if there are any special handling requirements.
Food and Drug Administration (FDA) in 2019 and is made by the pharmaceuticalcompany Janssen Pharmaceuticals. Spravato is a controlledsubstance. Spravato is also used to treat symptoms of depression in adults with depression who are having suicidal thoughts or behaviors. Spravato was approved by the U.S.
Containment and controlledsubstance capabilities are defining and necessary features for these manufacturing facilities, but not all contract manufacturers have the specialist equipment and capabilities required for high potency small molecule API production.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content